Open Access
BIO Web Conf.
Volume 86, 2024
International Conference on Recent Trends in Biomedical Sciences (RTBS-2023)
Article Number 01055
Number of page(s) 8
Published online 12 January 2024
  • T. J. Bartness, C. K. Song, H. Shi, R. R. Bowers, and M. T. Foster, “Brain–adipose tissue cross talk,” Proc. Nutr. Soc., vol. 64, no. 1, pp. 53–64, 2005, doi: 10.1079/pns2004409. [CrossRef] [PubMed] [Google Scholar]
  • P. Kanagasundaram et al., “Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis,” Frontiers in Psychiatry, vol. 12. Frontiers Media S.A., Mar. 17, 2021. doi: 10.3389/fpsyt.2021.642403. [CrossRef] [Google Scholar]
  • S. Kumari, M. Deori, R. Elancheran, J. Kotoky, and R. Devi, “In vitro and in vivo antioxidant, anti-hyperlipidemic properties and chemical characterization of Centella asiatica (L.) extract,” Front. Pharmacol., vol. 7, no. OCT, pp. 1–12, 2016, doi: 10.3389/fphar.2016.00400. [CrossRef] [Google Scholar]
  • A. Outman et al., “Obtaining of New Antioxidant and Antimicrobial Peptides Derived from Human Hemoglobin by Peptide Hydrolysis and Comparison with These Obtained by Bovine Hemoglobin,” 2023, doi: 10.20944/preprints202307. [Google Scholar]
  • M. Rahman AHM and M. M. Rahman, “Medicinal plants having anti-obesity potentiality available in Bangladesh: A review.,” Biol. Med. Case Reports, vol. 02, no. 01, 2018, doi: 10.35841/biology-medicine.2.1.4-11. [CrossRef] [Google Scholar]
  • H. Rouhi-Boroujeni, H. Rouhi-Boroujeni, E. Heidarian, F. Mohammadizadeh, and M. Rafieian-Kopaei, “Herbs with anti-lipid effects and their interactions with statins as a chemical antihyperlipidemia group drugs: A systematic review,” ARYA Atheroscler., vol. 11, no. 4, pp. 244–251, 2015. [Google Scholar]
  • W. Zheng et al., “Medicinal profile, phytochemistry, and pharmacological activities of murraya koenigii and its primary bioactive compounds,” Tjyybjb.Ac.Cn, vol. 11, no. 2, pp. 223–225, 2012, doi: 10.22037/ijpr.2012.1096. [Google Scholar]
  • G. F. Abdel Raoof, “Anti-Obesity Potential of Natural Products,” Egypt. J. Chem., vol. 65, no. 10, pp. 329–358, 2022, doi: 10.21608/EJCHEM.2022.118996.5354. [Google Scholar]
  • H. R. Bajes, I. Almasri, and Y. Bustanji, “Plant Products and Their Inhibitory Activity Against Pancreatic Lipase,” Rev. Bras. Farmacogn., vol. 30, no. 3, pp. 321–330, 2020, doi: 10.1007/s43450-020-00055-z. [CrossRef] [Google Scholar]
  • R. Balakrishnan, D. Vijayraja, S. H. Jo, P. Ganesan, I. Su-kim, and D. K. Choi, “Medicinal profile, phytochemistry, and pharmacological activities of murraya koenigii and its primary bioactive compounds,” Antioxidants, vol. 9, no. 2, 2020, doi: 10.3390/antiox9020101. [Google Scholar]
  • M. Bello, L. Basilio-Antonio, J. Fragoso-Vázquez, A. Avalos-Soriano, and J. Correa-Basurto, “Molecular recognition between pancreatic lipase and natural and synthetic inhibitors,” Int. J. Biol. Macromol., vol. 98, pp. 855–868, 2017, doi: 10.1016/j.ijbiomac.2017.01.150. [CrossRef] [Google Scholar]
  • R. Birari, V. Javia, and K. K. Bhutani, “Antiobesity and lipid lowering effects of Murraya koenigii (L.) Spreng leaves extracts and mahanimbine on high fat diet induced obese rats,” Fitoterapia, vol. 81, no. 8, pp. 1129–1133, 2010, doi: 10.1016/j.fitote.2010.07.013. [CrossRef] [PubMed] [Google Scholar]
  • A. Ceriello, “Perspectives in diabetes.,” J. Natl. Med. Assoc., vol. 54, pp. 476–478, 2005. [Google Scholar]
  • A. Rani, S. Kumar, and R. K. Khar, “In Vitro Antidiabetic and Hypolipidemic Activity of Selected Medicinal Plants,” Int. J. Pharm. Biol. Sci., vol. 9, no. 1, pp. 664–668, 2019, doi: 10.21276/ijpbs.2019.9.1.85. [Google Scholar]
  • P. Isolated, “NPC Natural Product Communications,” vol. 1, no. 4, pp. 9–12, 2010. [Google Scholar]
  • P. Gaur, K. Shanker, and A. Plants, “In-vitro Screening for of Alcohalic and Hydroalcohalic Extracts of Ayurvedic Medicinal Plants for the management of hyperlipidemia”. [Google Scholar]
  • M. K. Vinuthan, V. G. Kumar, J. P. Ravindra, P. S. P. Gupta, and S. J. Arun, “Changes in the Blood Lipid Profile After Administration of Murraya Koenigii Spreng (Curry Leaf) Extracts in the Normal Sprague Dawley Rats,” Indian J. Anim. Res., vol. 41, no. 3, pp. 223–225, 2015. [Google Scholar]
  • J. T. Xie et al., “Curry leaf (Murraya koenigii Spreng.) reduces blood cholesterol and glucose levels in ob/ob mice,” Am. J. Chin. Med., vol. 34, no. 2, pp. 279–284, 2006, doi: 10.1142/S0192415X06003825. [CrossRef] [PubMed] [Google Scholar]
  • R. Kant Upadhyay, “Antihyperlipidemic and cardioprotective effects of plant natural products: A review,” Int. J. Green Pharm., vol. 15, no. 1, p. 11, 2021, [Online]. Available: [Google Scholar]
  • R. S. Phatak, C. C. Khanwelkar, S. M. Matule, K. D. Datkhile, and A. S. Hendre, “Antihyperlipidemic activity of murraya koenigii leaves methanolic and aqueous extracts on serum lipid profile of high fat-fructose fed rats,” Pharmacogn. J., vol. 11, no. 4, pp. 836–841, 2019, doi: 10.5530/pj.2019.11.134. [CrossRef] [Google Scholar]
  • S. V. Tembhurne and D. M. Sakarkar, “Anti-obesity and hypoglycemic effect of ethanolic extract of Murraya koenigii (L) leaves in high fatty diet rats,” Asian Pacific J. Trop. Dis., vol. 2, no. SUPPL.1, pp. S166–S168, 2012, doi: 10.1016/S2222-1808(12)60145-5. [CrossRef] [Google Scholar]
  • A. N. Kesari, S. Kesari, S. K. Singh, R. K. Gupta, and G. Watal, “Studies on the glycemic and lipidemic effect of Murraya koenigii in experimental animals,” J. Ethnopharmacol., vol. 112, no. 2, pp. 305–311, 2007, doi: 10.1016/j.jep.2007.03.023. [CrossRef] [Google Scholar]
  • V. Gupta, Shailly, george, mathew, singhal, sharma N, Ganesh, Garg, “Material and Methods Plant material Carrageenan-induced edema in rats,” Mater. Methods Plant Mater. Carrageenan-induced edema rats, vol. 1, no. 1, pp. 68–77, 2010. [Google Scholar]
  • C. Igara, D. Omoboyowa, A. Ahuchaogu, N. Orji, and M. Ndukwe, “Phytochemical and nutritional profile of Murraya Koenigii (Linn) Spreng leaf CE Igara, DA Omoboyowa, AA Ahuchaogu, NU Orji and MK Ndukwe,” J. Pharmacogn. Phytochem., vol. 5, no. 5, pp. 4–7, 2016, [Online]. Available: [Google Scholar]
  • A. Phuyal, P. K. Ojha, B. Guragain, and N. K. Chaudhary, “Phytochemical screening, metal concentration determination, antioxidant activity, and antibacterial evaluation of Drymaria diandra plant,” Beni-Suef Univ. J. Basic Appl. Sci., vol. 8, no. 1, pp. 1–9, 2019, doi: 10.1186/s43088-019-0020-1. [CrossRef] [Google Scholar]
  • J. Y. Jeong, Y. H. Jo, K. Y. Lee, S. G. Do, B. Y. Hwang, and M. K. Lee, “Optimization of pancreatic lipase inhibition by Cudrania tricuspidata fruits using response surface methodology,” Bioorganic Med. Chem. Lett., vol. 24, no. 10, pp. 2329–2333, 2014, doi: 10.1016/j.bmcl.2014.03.067. [CrossRef] [Google Scholar]
  • S. L. Ong, S. Paneerchelvan, H. Y. Lai, and N. K. Rao, “In vitro lipase inhibitory effect of thirty two selected plants in Malaysia,” Asian J. Pharm. Clin. Res., vol. 7, no. SUPPL. 2, pp. 19–24, 2014. [Google Scholar]
  • N. Jaradat, “Anti-Lipase Potential of the Organic and Aqueous Extracts of Ten Traditional Edible and Medicinal Plants in Palestine ; a Comparison Study with Orlistat,” 2017, doi: 10.3390/medicines4040089. [Google Scholar]
  • O. A. Oluwagunwa, A. M. Alashi, and R. E. Aluko, “Inhibition of the in vitro Activities of α-Amylase and Pancreatic Lipase by Aqueous Extracts of Amaranthus viridis, Solanum macrocarpon and Telfairia occidentalis Leaves,” Front. Nutr., vol. 8, no. November, pp. 1–17, 2021, doi: 10.3389/fnut.2021.772903. [CrossRef] [Google Scholar]
  • X. Ji et al., “Bioactive compounds from herbal medicines to manage dyslipidemia,” Biomed. Pharmacother., vol. 118, p. 109338, Oct. 2019, doi: 10.1016/J.BIOPHA.2019.109338. [CrossRef] [Google Scholar]
  • S. M. Lim, Y. M. Goh, W. Bin Kuan, and S. P. Loh, “Effect of germinated brown rice extracts on pancreatic lipase, adipogenesis and lipolysis in 3T3-L1 adipocytes,” Lipids Health Dis., vol. 13, no. 1, pp. 1–9, 2014, doi: 10.1186/1476-511X-13-169. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.